rs7270101

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_StrongBA1

The NM_033453.4(ITPA):​c.124+21A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.115 in 1,613,972 control chromosomes in the GnomAD database, including 11,835 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as drug response (★★★).

Frequency

Genomes: 𝑓 0.096 ( 823 hom., cov: 32)
Exomes 𝑓: 0.12 ( 11012 hom. )

Consequence

ITPA
NM_033453.4 intron

Scores

2

Clinical Significance

drug response reviewed by expert panel B:3O:2

Conservation

PhyloP100: 0.323
Variant links:
Genes affected
ITPA (HGNC:6176): (inosine triphosphatase) This gene encodes an inosine triphosphate pyrophosphohydrolase. The encoded protein hydrolyzes inosine triphosphate and deoxyinosine triphosphate to the monophosphate nucleotide and diphosphate. This protein, which is a member of the HAM1 NTPase protein family, is found in the cytoplasm and acts as a homodimer. Defects in the encoded protein can result in inosine triphosphate pyrophosphorylase deficiency which causes an accumulation of ITP in red blood cells. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jun 2012]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64).
BP6
Variant 20-3213247-A-C is Benign according to our data. Variant chr20-3213247-A-C is described in ClinVar as [drug_response]. Clinvar id is 14747.Status of the report is reviewed_by_expert_panel, 3 stars. We mark this variant Likely_benign, oryginal submissions are: {drug_response=1, Benign=3}.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.127 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ITPANM_033453.4 linkc.124+21A>C intron_variant Intron 2 of 7 ENST00000380113.8 NP_258412.1 Q9BY32-1A0A0S2Z3W7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ITPAENST00000380113.8 linkc.124+21A>C intron_variant Intron 2 of 7 1 NM_033453.4 ENSP00000369456.3 Q9BY32-1

Frequencies

GnomAD3 genomes
AF:
0.0960
AC:
14592
AN:
152070
Hom.:
822
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0727
Gnomad AMI
AF:
0.0220
Gnomad AMR
AF:
0.0926
Gnomad ASJ
AF:
0.0806
Gnomad EAS
AF:
0.00116
Gnomad SAS
AF:
0.0247
Gnomad FIN
AF:
0.0645
Gnomad MID
AF:
0.0823
Gnomad NFE
AF:
0.130
Gnomad OTH
AF:
0.107
GnomAD2 exomes
AF:
0.0873
AC:
21964
AN:
251474
AF XY:
0.0866
show subpopulations
Gnomad AFR exome
AF:
0.0721
Gnomad AMR exome
AF:
0.0700
Gnomad ASJ exome
AF:
0.0760
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.0729
Gnomad NFE exome
AF:
0.127
Gnomad OTH exome
AF:
0.108
GnomAD4 exome
AF:
0.118
AC:
171805
AN:
1461784
Hom.:
11012
Cov.:
35
AF XY:
0.115
AC XY:
83336
AN XY:
727202
show subpopulations
Gnomad4 AFR exome
AF:
0.0732
AC:
2452
AN:
33480
Gnomad4 AMR exome
AF:
0.0729
AC:
3260
AN:
44724
Gnomad4 ASJ exome
AF:
0.0781
AC:
2042
AN:
26134
Gnomad4 EAS exome
AF:
0.000151
AC:
6
AN:
39700
Gnomad4 SAS exome
AF:
0.0308
AC:
2657
AN:
86258
Gnomad4 FIN exome
AF:
0.0780
AC:
4166
AN:
53420
Gnomad4 NFE exome
AF:
0.135
AC:
150519
AN:
1111908
Gnomad4 Remaining exome
AF:
0.103
AC:
6233
AN:
60392
Heterozygous variant carriers
0
8908
17816
26725
35633
44541
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
5344
10688
16032
21376
26720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0959
AC:
14593
AN:
152188
Hom.:
823
Cov.:
32
AF XY:
0.0912
AC XY:
6784
AN XY:
74404
show subpopulations
Gnomad4 AFR
AF:
0.0727
AC:
0.0726739
AN:
0.0726739
Gnomad4 AMR
AF:
0.0924
AC:
0.0923842
AN:
0.0923842
Gnomad4 ASJ
AF:
0.0806
AC:
0.0806452
AN:
0.0806452
Gnomad4 EAS
AF:
0.00116
AC:
0.0011592
AN:
0.0011592
Gnomad4 SAS
AF:
0.0247
AC:
0.0246786
AN:
0.0246786
Gnomad4 FIN
AF:
0.0645
AC:
0.0645405
AN:
0.0645405
Gnomad4 NFE
AF:
0.130
AC:
0.129519
AN:
0.129519
Gnomad4 OTH
AF:
0.105
AC:
0.105487
AN:
0.105487
Heterozygous variant carriers
0
687
1375
2062
2750
3437
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
158
316
474
632
790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.113
Hom.:
1662
Bravo
AF:
0.0980
Asia WGS
AF:
0.0180
AC:
63
AN:
3478

ClinVar

Significance: drug response
Submissions summary: Benign:3Other:2
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

Inosine triphosphatase deficiency Benign:1Other:1
Oct 01, 2002
OMIM
Significance:Affects
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Jan 22, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Developmental and epileptic encephalopathy, 35 Benign:1
Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
May 12, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 19579612, 12384777, 20547162, 22613675, 17113761, 20173735, 22939045) -

peginterferon alfa-2b and ribavirin response - Toxicity Other:1
Mar 24, 2021
PharmGKB
Significance:drug response
Review Status:reviewed by expert panel
Collection Method:curation

PharmGKB Level of Evidence 2B: Variants in Level 2B clinical annotations are not in PharmGKB’s Tier 1 VIPs. These clinical annotations describe variant-drug combinations with a moderate level of evidence supporting the association. For example, the association may be found in multiple cohorts, but there may be a minority of studies that do not support the majority assertion. Level 2B clinical annotations must be supported by at least two independent publications. Drug-variant association: Toxicity

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.64
CADD
Benign
17
DANN
Benign
0.75
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.15
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs7270101; hg19: chr20-3193893; COSMIC: COSV66318589; API